NCT06410274

Brief Summary

The aim of this observational study is to determine how and why inadequate brain blood flow occurs after bleeding in patients with intracerebral haemorrhage (ICH). Treatment for strokes caused by burst blood vessels involves reducing blood pressure (BP) to stop the bleeding. However, this reduction in BP may affect blood flow, causing blockages in blood vessels within the brain. Fast breathing also affects brain blood flow. Therefore, participants will be asked to undergo a simple brain blood flow assessment using transcranial Doppler (TCD) within 48 hours upon admission to hospital. Patients will then have a follow-up TCD assessment at 4-7 days post-ICH onset, in addition to an MRI scan at \>7 days. This research will help to confirm if blockages after bleeding are caused by reduced blood flow within the brain.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
33mo left

Started Jun 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Jun 2024Jan 2029

First Submitted

Initial submission to the registry

May 7, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 13, 2024

Completed
19 days until next milestone

Study Start

First participant enrolled

June 1, 2024

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2029

Last Updated

September 19, 2024

Status Verified

April 1, 2024

Enrollment Period

4.7 years

First QC Date

May 7, 2024

Last Update Submit

September 17, 2024

Conditions

Keywords

StrokeCerebral AutoregulationCerebral Blood FlowTranscranial DopplerMagnetic Resonance Imaging

Outcome Measures

Primary Outcomes (4)

  • Cerebral blood velocity measurements within 48 hours of admission to hospital and 4-7 days after onset in intracerebral haemorrhage patients.

    Absolute values (cm/s) in cerebral blood velocity measurements in intracerebral haemorrhage patients.

    From enrolment to the end of the follow-up (7 days).

  • Cerebral blood velocity measurements within 48 hours of admission to hospital and 4-7 days after onset in intracerebral haemorrhage patients.

    Percentage change (%) in cerebral blood velocity measurements in intracerebral haemorrhage patients.

    From enrolment to the end of the follow-up (7 days).

  • End-tidal carbon dioxide measurements within 48 hours of admission to hospital and 4-7 days after onset in intracerebral haemorrhage patients.

    Absolute values (mmHg) in end-tidal carbon dioxide measurements in intracerebral haemorrhage patients.

    From enrolment to the end of the follow-up (7 days).

  • End-tidal carbon dioxide measurements within 48 hours of admission to hospital and 4-7 days after onset in intracerebral haemorrhage patients.

    Percentage change (%) in end-tidal carbon dioxide measurements in intracerebral haemorrhage patients.

    From enrolment to the end of the follow-up (7 days).

Secondary Outcomes (2)

  • Arterial spin labelling magnetic resonance imaging measurements >7 days post-intracerebral haemorrhage onset.

    From enrolment to the magnetic resonance imaging scan (<7 days post-intracerebral haemorrhage onset).

  • Arterial spin labelling magnetic resonance imaging measurements >7 days post-intracerebral haemorrhage onset.

    From enrolment to the magnetic resonance imaging scan (<7 days post-intracerebral haemorrhage onset).

Study Arms (1)

Intracerebral Haemorrhage Patients

Patients with a clinical diagnosis of haemorrhagic stroke on CT imaging within 48 hours of onset (for patients waking with a stroke, time of onset will be taken to be the time when the patient was last asymptomatic). This is a non-intervention study so no intervention will be given. However, the investigators will observe changes in cerebral haemodynamics of this group within 48 hours of stroke onset and within 3-7 days post-onset.

Device: Transcranial Doppler ultrasonography (TCD)

Interventions

TCD will be used to measure cerebral blood velocity (CBv) in the middle and posterior cerebral arteries (MCA and PCA). Following confirmation of a suitable TCD window, participants will undergo a ten-minute rest period in the supine or semi-supine position. Continuous measurements of CBv, blood pressure (BP), heart rate, and end-tidal carbon dioxide will be recorded. Baseline BP will be measured using an automated BP device prior to each recording to allow calibration of the files offline for analysis. This will occur at the first visit and at follow-up, 4-7 days post-onset of intracerebral haemorrhage.

Intracerebral Haemorrhage Patients

Eligibility Criteria

Age18 Years - 120 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The participants will be recruited from the Leicester Royal Infirmary stroke wards.

You may qualify if:

  • Clinical diagnosis of a haemorrhagic stroke on CT imaging within 48 hours of onset (for patients waking with a stroke, time of onset will be taken to be the time when the patient was last asymptomatic).
  • Male or female, aged 18 years or above.

You may not qualify if:

  • MRI imaging is contraindicated or unlikely to tolerate scanning process due to clinical instability (GCS \<8, unable to lie supine).
  • Patients requiring anaesthesia.
  • Male or Female, aged under 18 years.
  • Clinical diagnosis of stroke greater than 48 hours from onset

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals of Leicester NHS Trust

Leicester, LE1 5WW, United Kingdom

RECRUITING

MeSH Terms

Conditions

Cerebral HemorrhageStroke

Interventions

Ultrasonography, Doppler, Transcranial

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

EchoencephalographyNeuroradiographyNeuroimagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisRadiographyUltrasonographyUltrasonography, DopplerDiagnostic Techniques, NeurologicalInvestigative Techniques

Central Study Contacts

Jatinder Minhas, SFHEA

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 7, 2024

First Posted

May 13, 2024

Study Start

June 1, 2024

Primary Completion (Estimated)

January 31, 2029

Study Completion (Estimated)

January 31, 2029

Last Updated

September 19, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Individual patient data will not be shared, however once analysed and combined (statistically through mean averages etc), the results will be compiled into a report and submitted to a relevant journal, allowing researchers to view them.

Locations